WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke
... suspected stroke at WVU's Ruby Memorial Hospital. Only patients who had a follow up MRI scan within one week 422 -- were included in the analysis. ctp abnormalities in these patients were compared with subsequent diffused weighted image (DWI) abnormalities seen on follow up MRI scans. Magnetic r...Modigene Platform Validated in Independent Phase III Trial of CTP Technology
- Validates the Clinical Utility of Modigene's CTP Technology for Extending the Duration of Action of Therapeutic Proteins - NES-ZIONA, Israel, July 10 /PRNewswire-FirstCall/ -- Modigene Inc., (OTC Bulletin Board: MODG) today noted the successful completion of a Phase III clinical tri...PROLOR Biotech Acquires License Option from Yeda for Development of Long-Acting Anti-Obesity Drug
...plying unique technologies, including its patented ctp technology, primarily to develop longer-acting, pr...e billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins...ements. The development of any products using the ctp platform technology could also be affected by a nu...PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
... a biopharmaceutical company applying its patented ctp technology to develop longer-acting, proprietary v...e billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins...ements. The development of any products using the ctp platform technology could also be affected by a nu...Modigene Shareholders Approve Company Name Change and Other Proposals at Annual Meeting
...LOngevity Redefined--reflects our company's unique ctp technology that has been proven to significantly e... a biopharmaceutical company applying its patented ctp technology to develop longer-acting, proprietary v...te billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins...Modigene to Present at the BIO-Europe Spring(R) 2009 Conference
...GENE Modigene Inc. is a biopharmaceutical company applying its patented ctp technology to develop longer-acting, proprietary versions of already approv...ns that currently generate billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins, and Modigene is current...Modigene Sets Record Date for Annual Meeting of Shareholders
...GENE Modigene Inc. is a biopharmaceutical company applying its patented ctp technology to develop longer-acting, proprietary versions of already-approv...ns that currently generate billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins, and Modigene is current...Modigene to Present at the UBS Global Life Sciences Conference
...p longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins, and Modigene is currently developing long-acting versions of human growth hormone, interferon beta...Modigene to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
...p longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins, and Modigene is currently developing long-acting versions of human growth hormone, interferon beta...Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
...cid sequence, the carboxyl terminal peptide (CTP). ctp occurs naturally in humans, and when attached to a... These trials also demonstrated that attaching the ctp peptide did not affect the therapeutic activity of...sive license from Washington University for use of ctp with all therapeutic proteins except four fertilit...